医学
黄褐斑
半胱胺
皮肤病科
安慰剂
临床疗效
临床试验
随机对照试验
起效
药理学
内科学
病理
替代医学
作者
Mukta Sachdev,Pearl E. Grimes,Valerie Callender,Corey L. Hartman,Susan C. Taylor,Nada Elbuluk,Ashraf Badawi,Yoko Funasaka,Joyce Lim,Chau Yee Ngee,Seemal R. Desai
摘要
Background: Modified Kligman's formula (mKF) is the gold standard treatment for melasma; however, its prolonged use is not recommended due to side effects. Cysteamine is a potent, safe, and effective depigmenting agent. Here, we conducted a double-blind, randomized, and placebo-controlled clinical trial to assess the efficacy of cysteamine isobionic-amide -- a complex with enhanced depigmenting efficacy -- and compared it to mKF for the treatment of melasma.
科研通智能强力驱动
Strongly Powered by AbleSci AI